Perry M E, Commane M, Stark G R
Imperial Cancer Research Fund, London, United Kingdom.
Proc Natl Acad Sci U S A. 1992 Sep 1;89(17):8112-6. doi: 10.1073/pnas.89.17.8112.
Gene amplification is characteristic of tumors and continuous cell lines but not of primary, normal, diploid, senescing cells. However, the rat cell line REF52, which resembles primary cells in requiring expression of cooperating oncogenes for transformation, is unusual among cell lines as it is not permissive for amplification. REF52 cells did not form colonies in N-(phosphonacetyl)-L-aspartate (PALA), a drug for which the only known mechanism of resistance is amplification of the carbamoylphosphate synthetase/aspartate transcarbamoylase/dihydroorotase (CAD) gene. Colonies did form in a low concentration of methotrexate but did not contain amplified dihydrofolate reductase genes. Expression of two cooperating oncogenes in REF52 cells converted them to a state permissive for amplification. Cells expressing only the 12S E1A mRNA of adenovirus 5 did not give rise to PALA-resistant colonies, but expression of an activated ras gene together with E1A readily allowed the cells to form resistant colonies in which the CAD gene was amplified. Cells expressing E1A plus ras were fully transformed, but expression of simian virus 40 large tumor antigen alone converted REF52 cells to a state permissive for amplification without transforming them fully. The ability to manipulate gene amplification in REF52 cells by expression of oncogenes should contribute to an understanding of the nature of the permissive state.
基因扩增是肿瘤和连续细胞系的特征,而原代、正常、二倍体、衰老细胞则不具备此特征。然而,大鼠细胞系REF52在细胞系中较为特殊,它类似于原代细胞,转化需要协同癌基因的表达,且不允许基因扩增。REF52细胞在N-(膦酰乙酰基)-L-天冬氨酸(PALA)中不能形成集落,PALA是一种药物,已知的唯一耐药机制是氨甲酰磷酸合成酶/天冬氨酸转氨甲酰酶/二氢乳清酸酶(CAD)基因的扩增。在低浓度甲氨蝶呤中可形成集落,但不含扩增的二氢叶酸还原酶基因。REF52细胞中两个协同癌基因的表达使其转变为允许基因扩增的状态。仅表达腺病毒5的12S E1A mRNA的细胞不会产生对PALA耐药的集落,但激活的ras基因与E1A共同表达能使细胞轻易形成耐药集落,其中CAD基因被扩增。表达E1A加ras的细胞完全转化,但仅表达猿猴病毒40大肿瘤抗原可使REF52细胞转变为允许基因扩增的状态,却不能使其完全转化。通过癌基因表达来操控REF52细胞中基因扩增的能力,应有助于理解允许状态的本质。